跳至主要内容
临床试验/CTRI/2026/07/113820
CTRI/2026/07/113820进行中(未招募)3 期

Evaluating The Effectiveness Of Individualised Homoeopathic Medicines Vs Chelidonium Majus 3x In Treatment Of Non - Alcoholic Fatty Liver Disease : A Randomised, Controlled Clinical Trial - NIL

Dr Prachi Khatri0 个研究点目标入组 60 人开始时间: 2026年7月18日最近更新:

试验速览

阶段
3 期
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Individuals with grade 1 and 2 fatty liver established by ultrasonography.
  • Both sexes of age group above 18 years and below 60 years, irrespective of their race, caste,
  • religion & socioeconomic status.
  • Individuals with no history of alcohol or alcohol consumption less than threshold level (30
  • g/day for males and 20 g/day for females).

排除标准

  • Patients suffering from systemic illness with life threatening complications.
  • Patients with complications like liver cirrhosis, hepatocellular carcinoma, cardiac failure.
  • Patients suffering from any other chronic liver disease like hepatitis B or C.
  • Patients who are under any other treatment for the same complaint.
  • Pregnant or lactating women
  • Patients with psychiatric disease, and those with immunocompromised state.
  • Substance abuse and/or dependence.

研究者

发起方
Dr Prachi Khatri

相似试验